Oracle (ORCL)
(Delayed Data from NYSE)
$142.76 USD
+0.69 (0.49%)
Updated Jul 11, 2024 04:00 PM ET
After-Market: $142.78 +0.02 (0.01%) 7:58 PM ET
3-Hold of 5 3
C Value C Growth C Momentum C VGM
Brokerage Reports
Oracle Corporation [ORCL]
Reports for Purchase
Showing records 721 - 740 ( 912 total )
Company: Oracle Corporation
Industry: Computer - Software
Company: Oracle Corporation
Industry: Computer - Software
Company: Oracle Corporation
Industry: Computer - Software
Morning Meeting Notes
Provider: KEYBANC CAPITAL MARKETS
Company: Oracle Corporation
Industry: Computer - Software
2Q May Be an Inflection, But We Think Any Improvement Will Be Mild; Reiterate NEUTRAL and $40 PT
Provider: WEDBUSH SECURITIES INC.
Analyst: KOENIG S
Company: Oracle Corporation
Industry: Computer - Software
Company: Oracle Corporation
Industry: Computer - Software
Expect Macro and Currency Headwinds, Cloud Traction; Reiterate NEUTRAL and $40 PT
Provider: WEDBUSH SECURITIES INC.
Analyst: KOENIG S
Company: Oracle Corporation
Industry: Computer - Software
Morning Meeting Notes
Provider: KEYBANC CAPITAL MARKETS
Company: Oracle Corporation
Industry: Computer - Software
Company: Oracle Corporation
Industry: Computer - Software
Company: Oracle Corporation
Industry: Computer - Software
Morning Meeting Notes
Provider: KEYBANC CAPITAL MARKETS
Company: Oracle Corporation
Industry: Computer - Software
Company: Oracle Corporation
Industry: Computer - Software
Company: Oracle Corporation
Industry: Computer - Software
Company: Oracle Corporation
Industry: Computer - Software
Company: Oracle Corporation
Industry: Computer - Software
Company: Oracle Corporation
Industry: Computer - Software
Company: Oracle Corporation
Industry: Computer - Software
Company: Oracle Corporation
Industry: Computer - Software
Morning Meeting Notes
Provider: KEYBANC CAPITAL MARKETS
Company: Oracle Corporation
Industry: Computer - Software
Enterprise Software: Manufacturing Weakness is a Headwind for PTC and ANSS, But Company-Specific Catalysts Look Probable
Provider: WEDBUSH SECURITIES INC.
Analyst: KOENIG S